Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent

α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted t...

Full description

Bibliographic Details
Main Authors: Elsaid Ali, Aimen Abdo, Bakhtiar, M. Taher, Mohamed, Farahidah
Format: Conference or Workshop Item
Language:English
Published: 2011
Subjects:
Online Access:http://irep.iium.edu.my/12374/
http://irep.iium.edu.my/12374/
http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf
id iium-12374
recordtype eprints
spelling iium-123742014-12-09T01:31:46Z http://irep.iium.edu.my/12374/ Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah RM300 Drugs and their action RS Pharmacy and materia medica α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted to encapsulate the α-mangostin into biodegradable PLGA copolymer using colloidal extraction solvent evaporation method. The polysaccharide Chitosan was incorporated with the loaded nanoparticles to improve their affinity towards lung cancer cells. The resultant nanoparticles were characterized for their size distribution and external morphology by laser diffractometry and scanning electron microscope (SEM), respectively. The concentration of entrapped α-mangostin was determined by HPLC. Our data demonstrated that the encapsulation efficiency for Chitosan-α-mangostin-loaded PLGA nanoparticles (CM-NP) was higher than those without Chitosan (M-NP). The in vitro release from (CM-NP) and (NPM) was carried out in PBS containing 0.1% tween 20 over three weeks. Whereas, in vitro anti-cancer activities of (CM-NP) and (M-NP) were evaluated against lung cancer cell line (A549) and compared to the free α-mangostin. Our data revealed that (CM-NP) showed higher cytotoxic effect compared to (M-NP) and both had lower cytotoxicity than free α-mangostin. In conclusion, PLGA nanoparticles in combination with Chitosan may be used as a promising composite micro-carrier system to deliver α-mangostin to the lung cancer tissue. 2011 Conference or Workshop Item PeerReviewed application/pdf en http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf Elsaid Ali, Aimen Abdo and Bakhtiar, M. Taher and Mohamed, Farahidah (2011) Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent. In: International Postgraduate Conference on Biotechnology (IPBC) 2011, 15-18 Dec 2011, Kuala Terengganu. http://imb.umt.edu.my/ipcb2011/
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RM300 Drugs and their action
RS Pharmacy and materia medica
spellingShingle RM300 Drugs and their action
RS Pharmacy and materia medica
Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
description α-Mangostin is one of the main active constituents that can be isolated from the stem bark of Garcinia malaccensis (GM) and has been documented to exert different cytotoxic activities against many cancerous cell lines. Due to its non selective distribution into the tissue, this study had attempted to encapsulate the α-mangostin into biodegradable PLGA copolymer using colloidal extraction solvent evaporation method. The polysaccharide Chitosan was incorporated with the loaded nanoparticles to improve their affinity towards lung cancer cells. The resultant nanoparticles were characterized for their size distribution and external morphology by laser diffractometry and scanning electron microscope (SEM), respectively. The concentration of entrapped α-mangostin was determined by HPLC. Our data demonstrated that the encapsulation efficiency for Chitosan-α-mangostin-loaded PLGA nanoparticles (CM-NP) was higher than those without Chitosan (M-NP). The in vitro release from (CM-NP) and (NPM) was carried out in PBS containing 0.1% tween 20 over three weeks. Whereas, in vitro anti-cancer activities of (CM-NP) and (M-NP) were evaluated against lung cancer cell line (A549) and compared to the free α-mangostin. Our data revealed that (CM-NP) showed higher cytotoxic effect compared to (M-NP) and both had lower cytotoxicity than free α-mangostin. In conclusion, PLGA nanoparticles in combination with Chitosan may be used as a promising composite micro-carrier system to deliver α-mangostin to the lung cancer tissue.
format Conference or Workshop Item
author Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
author_facet Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
author_sort Elsaid Ali, Aimen Abdo
title Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
title_short Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
title_full Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
title_fullStr Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
title_full_unstemmed Development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
title_sort development of chitosan-α-mangostin loaded nanoparticles as an anticancer agent
publishDate 2011
url http://irep.iium.edu.my/12374/
http://irep.iium.edu.my/12374/
http://irep.iium.edu.my/12374/1/IPBS_poster_%25282%2529.pdf
first_indexed 2023-09-18T20:21:36Z
last_indexed 2023-09-18T20:21:36Z
_version_ 1777408143363407872